Results 241 to 250 of about 61,634 (258)

Compulsive eating and weight gain related to dopamine agonist use

Movement Disorders, 2006
Melissa J Nirenberg, Cheryl Waters
exaly  

Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists

European Journal of Pharmacology, 1996
Montford F Piercey, M W Smith
exaly  

Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors

European Journal of Pharmacology, 2008
Yoshihiro Tadori, Tetsuro Kikuchi
exaly  

Dopamine Agonist Withdrawal Syndrome: Implications for Patient Care

Drugs and Aging, 2013
Melissa J Nirenberg
exaly  

A Pilot Prospective, Multicenter Observational Study of Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease

Movement Disorders Clinical Practice, 2015
K Ray Chaudhuri, Melissa J Nirenberg, Miriam Parry   +2 more
exaly  

DOPAMINE AGONISTS AND REFLEX EPILEPSY

1977
G M, Anlezark, R W, Horton, B S, Meldrum
openaire   +2 more sources

Treatment of parkinson's disease with the partial dopamine agonist EMD 49980

Movement Disorders, 1993
D Bravi, Thomas L Davis, M Maral Mouradian   +2 more
exaly  

Pramipexole — a new dopamine agonist for the treatment of Parkinson's disease

Journal of the Neurological Sciences, 1999
James P Bennett, Montford F Piercey
exaly  

Dopamine Agonist Therapy for Hyperprolactinemia

Clinical Obstetrics and Gynecology, 2003
Brandon J, Bankowski, Howard A, Zacur
openaire   +2 more sources

Dopamine agonist monotherapy in Parkinson's disease

Lancet, The, 2002
C E Clarke, M Guttman
exaly